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Background: Inﬂuenza A H1N1 re emerged in 2009 causing a
pandemic and continues to circulate worldwide seasonally. This
studywasundertaken tocharacterize InﬂuenzaAH1N1 ina tertiary
care center over six years.
Methods & Materials: Throat swabs/nasopharyngeal samples
were collected from patients who reported an inﬂuenza like ill-
ness(ILI)sent in viral transport medium in refrigerated condition to
the laboratory. RNAwas extracted from the clinical specimens. One
step Real Time Reverse Transcriptase Polymerase Chain Reaction
was performed (Ambion kit) using speciﬁc primers (INF A, univer-
sal SwineA, Swine H1 and RNaseP) and the Taqman probe (CDC
protocol). Ampliﬁcation was performed using Real time PCR (ABI
7900HT) system (reverse transcription for 30min at 500C and ini-
tial activation for 10min at 950C followed by 45 cycles of primer
annealing and extension at 950C for 15sec and 550C for 30sec).
Results: A total of 2382 sampleswere analyzed, n =480(20.15%)
tested positive for novel Inﬂuenza A H1N1 and n=102 (4.28%)
tested positive for seasonal inﬂuenza A. The positivity rate was
46.08% in 2009, fell from 15.02% (2010), to 1% by 2011; was 22%
in 2012 just 1.86% in 2013, 7.096% in 2014 and is currently 44.2% as
of Oct 2015. The age of patients ranged from 10 days to >81 years.
InﬂuenzaAh1n1 accounted for 25.35% of ILI in children (0-18 years)
. The rate of positivity in adults was found to be similar across age
groups of 21-60 years (range 19.7%- 21.1%) and declined to 13.5%
in greater than 61 years of age. Cough (84.2%)was the predominant
symptom, followed by fever (83.75%), breathlessness (55.2%), body
ache (54.8%), vomiting (21.4%), diarrhoea (9.58%), 4.4% gave history
of travel abroad. Based on the duration of illness the rate of posi-
tivity was found to be 78.54% from day one to day 7 of ILI. However
5.62% were positive between day 10 to 30.
Conclusion: There is a cyclical occurrence in the seasonality of
Inﬂuenza H1N1. Vulnerable groups such as pregnant and lactating
mothers may require targeted intervention.
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Background: Hand, foot and mouth disease (HFMD) is an
emerging infection in Asia. Neurological complication and fatality
are typically associated with enterovirus A71 (EV-A71). Intra-
venous immunoglobulin (IVIg) is widely used in the treatment of
severe cases, albeit without clinical evidence. This study charac-
terized clinical features, virology, cytokine proﬁles and immune
responses in severe HFMD children receiving IVIg.
Methods&Materials: Aprospective studywas conducted in the
ICU of Children’s Hospital 2 (Ho Chi Minh City, Vietnam) from June
to September 2012 enrolled HFMD children with clinical indica-
tion to have CSF taken. Clinical data, diagnostic throat/rectal swabs,
CSF after IVIg, plasma before and after IVIg and at discharge were
collected. Plasma cytokines/chemokines and antibodies against
common HFMD associated viruses were assessed before and after
IVIg and at discharge. Cytokines/chemokines were assessed in CSF.
Results: Thirty patients were enrolled (grade 2b, n=15, grade
3, 13 and grade 4, 2). Twenty-ﬁve patients recovered, 2 died and
3 with unknown outcome due to withdrawing. Clinical charac-
teristics improved within 48 hours of admission in grade 2b and
after 72 hours in grade 3 patients, coinciding with 1st and 2nd
doses of IVIg administration. EV-A71 was detected in swabs of 25
patients and in CSF of 1, and other EVs in swabs of 3. The level of
10 cytokines/chemokines in CSFwas comparable between patients
receiving one and two IVIg doses, which were also unchanged
before and after IVIg in plasma. At discharge, plasma IL-1, IL-6, IL-
10, GM-CSF and IFN-were signiﬁcantly decreased (Figure 1). CSF
IL-1, IL-4, IL-10 and TNF- were signiﬁcantly lower as compared
to that in plasma after IVIg. In contrast, CSF IL-6 was signiﬁcantly
higher than that in plasma after the 2nd IVIg (P <0.05) (Figure 2).
Before IVIg, plasma neutralizing antibody levels against EV-A71
subgenogroupC4andB5werehighbut that against CV-A10/A16/12
were low (Figure 3). These titers increased after IVIg except for that
against CV-A12.
